POSITRON CORP POSC
OTC · OOTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1994-02-10
POSITRON CORP financials (annual, from 10-K)
Bars are annual figures from 2010 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Revenue | $461,452 | $587,500 | $1.5M | $1.6M | $2.8M | $6.7M | $4.6M |
| Gross profit | -$2.1M | -$341,984 | $104,000 | $424,000 | $829,000 | $277,000 | $59,000 |
| R&D expense | — | — | $471,000 | $564,000 | $940,000 | $1.3M | $1.3M |
| Operating income | -$10.5M | -$2.2M | -$2.7M | -$3.3M | -$4.7M | -$4.4M | -$14.4M |
| Interest expense | $125,338 | $142,402 | $1.8M | $2.1M | $1.8M | $1.2M | $43,000 |
| Income tax | — | — | $0 | $0 | $0 | — | — |
| Net income | -$10.6M | -$2.4M | -$2.6M | -$7.1M | -$8.0M | -$6.1M | -$10.9M |
| EPS (diluted) | $-0.34 | $-0.09 | — | — | — | — | — |
| Operating cash flow | -$4.7M | -$1.7M | -$2.4M | -$3.0M | -$2.2M | -$4.1M | -$4.7M |
| Free cash flow | — | — | -$2.4M | -$3.1M | -$2.3M | -$4.1M | -$4.9M |
| Cash & equivalents | — | — | $208,000 | $1.7M | $243,000 | $1,000 | $1.1M |
| Inventory | $680,000 | $1.3M | $330,000 | $547,000 | $551,000 | $741,000 | $622,000 |
| Total assets | $4.0M | $1.8M | $1.9M | $3.9M | $2.7M | $2.3M | $5.2M |
| Total liabilities | $2.6M | $2.5M | $2.7M | $15.1M | $8.9M | $5.2M | $5.3M |
| Shareholders' equity | $1.4M | -$656,725 | -$837,000 | -$11.2M | -$6.2M | -$2.9M | -$86,000 |
Growth · year-over-year · Revenue CAGR -31.9%
| Metric | FY2025 | FY2024 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|
| Revenue growth | -21.5% | -59.9% | -10.1% | -41.8% | -58.0% | +44.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000844985 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.